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Abstract
Background: Musculoskeletal conditions (MSCs) are widely prevalent in present-day society, with resultant high
healthcare costs and substantial negative effects on patient health and quality of life. The main aim of this overview
was to synthesize evidence from systematic reviews on the effects of exercise therapy (ET) on pain and physical
function for patients with MSCs. In addition, the evidence for the effect of ET on disease pathogenesis, and whether
particular components of exercise programs are associated with the size of the treatment effects, was also explored.
Methods: We included four common conditions: fibromyalgia (FM), low back pain (LBP), neck pain (NP), and
shoulder pain (SP), and four specific musculoskeletal diseases: osteoarthritis (OA), rheumatoid arthritis (RA),
ankylosing spondylitis (AS), and osteoporosis (OP). We first included Cochrane reviews with the most recent update
being January 2007 or later, and then searched for non-Cochrane reviews published after this date. Pain and
physical functioning were selected as primary outcomes.
Results: We identified 9 reviews, comprising a total of 224 trials and 24,059 patients. In addition, one review
addressing the effect of exercise on pathogenesis was included. Overall, we found solid evidence supporting ET in
the management of MSCs, but there were substantial differences in the level of research evidence between the
included diagnostic groups. The standardized mean differences for knee OA, LBP, FM, and SP varied between 0.30
and 0.65 and were significantly in favor of exercise for both pain and function. For NP, hip OA, RA, and AS, the
effect estimates were generally smaller and not always significant. There was little or no evidence that ET can
influence disease pathogenesis. The only exception was for osteoporosis, where there was evidence that ET
increases bone mineral density in postmenopausal women, but no significant effects were found for clinically
relevant outcomes (fractures). For LBP and knee OA, there was evidence suggesting that the treatment effect
increases with the number of exercise sessions.
Conclusions: There is empirical evidence that ET has beneficial clinical effects for most MSCs. Except for
osteoporosis, there seems to be a gap in the understanding of the ways in which ET influences disease
mechanisms.
Keywords: fibromyalgia, low back pain, neck pain, shoulder pain, osteoarthritis, rheumatoid arthritis, ankylosing
spondylitis, osteoporosis, pain, physical function
Background
Musculoskeletal conditions (MSCs) are common, and
have important consequences for the individual and for
society. MSCs are the most common cause of severe
long-term pain and physical disability, and in Europe, 20
to 30% of adults are affected at any one time [1-3]. It is
estimated that MSCs represent nearly 25% of the total
cost of illness in Sweden [4], and they are one of the
most common causes of health problems limiting work
ability [5]. About one in five consultations in primary
care are for MSCs, and some of these patients are
referred to other health professionals such as phy-
siotherapists, occupational therapists, or chiropractors,
to medical specialists such as rheumatologists, or to
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orthopedic surgeons. The burden that MSCs create has
been recognized by the United Nations and WHO, with
their endorsement of the Bone and Joint Decade 2000
to 2010 [6]. The prevalence of many of these conditions
increases markedly with age, and many patients also
have some common lifestyle factors (obesity, smoking,
and physical inactivity). With the increasing number of
older people and the ongoing changes in lifestyle, the
burden of MSCs and other non-communicable diseases
is predicted to increase [7].
MSCs form a heterogeneous group of over 200 different
health problems that are linked anatomically and also
linked by their association with pain and impaired physical
function [8]. They range from conditions of acute onset
and short duration to lifelong disorders. For many com-
mon MSCs such as regional pain syndromes, the underly-
ing pathogenesis is poorly understood, and it is often not
possible to produce a clear-cut diagnosis. Some, such as
osteoarthritis (OA), are biologically well defined but clini-
cally less well understood, whereas others, such as rheu-
matoid arthritis (RA) are both biologically and clinically
well defined [9].
For decades, inactivity and bed rest were the mainstays
of the management of many diseases, but there is now an
increasing amount of evidence supporting the opposite
view; that is, that physical activity and exercise are benefi-
cial to health promotion and treatment. Although exercise
and physical activity are closely related constructs, they
have distinct meanings. The term ‘physical activity’
includes everyday activities that can contribute to well-
being, whereas ‘exercise’ is physical activity that is planned,
structured and repetitive [10]. The focus of this overview
is exercise therapy (ET), which involves the prescription of
a physical-activity program that involves the client under-
taking voluntary muscle contraction and/or body move-
ment with the aim of relieving symptoms or improving
function, or of improving, retaining, or slowing deteriora-
tion of health [11].
Whereas systematic reviews of randomized trials usually
summarize the evidence of one kind of intervention for a
single condition, overviews of systematic reviews can sum-
marize evidence from more than one systematic review of
the same intervention for different conditions. There is, to
our knowledge, only one published overview of systematic
reviews that has focused on the effects of exercises for
MSCs [12]. This overview was based on reviews published
up to July 2007, and did not include specific diseases such
as osteoporosis and inflammatory joint diseases. Thus, the
most updated evidence may not be included in this over-
view. The main aim of the present overview was to synthe-
size evidence from systematic reviews on the effects of ET
on pain and physical function for eight selected MSCs. In
addition, we explored the evidence for the effect of ET on
disease pathogenesis, and whether particular components
of exercise programs are associated with the size of the
treatment effects.
Methods
Criteria for considering reviews for inclusion
For this overview, we included systematic reviews on the
effects of ET for four common conditions (FM, low back
pain (LBP), neck pain (NP), and shoulder pain (SP)) and
four specific musculoskeletal diseases (OA, RA, ankylosing
spondylitis (AS), and osteoporosis). Other related condi-
tions and musculoskeletal malformations and traumas
were not included in this overview. All types of land-based
ET interventions were considered.
Search methods for the identification of reviews
The first search, of the Cochrane database of systematic
reviews, was performed in March 2012. All Cochrane
reviews on exercises for the aforementioned MSCs were
considered for inclusion. Two authors (GS and KBH)
assessed the eligibility of reviews based on the inclusion
criteria presented above. Cochrane reviews with the most
recent update of January 2007 or before were not included,
and we replaced these reviews by searching for non-
Cochrane systematic reviews in MEDLINE, EMBASE,
CINAHL, AMED, and PEDro, published after this date
(for the electronic search strategy for MEDLINE, see
Additional file 1). Two authors (GS and KBH) then
screened these records for new reviews. If several reviews
fulfilled the inclusion criteria, we included only one review
per combination of disease, intervention, and outcome by
choosing the newest review of high quality. If two or more
reviews were equal for these criteria, we chose the review
with the highest number of primary studies. We also
searched in the same databases for reviews with the expli-
cit aim of investigating the effect of exercise on the patho-
genesis of MSCs, with no restrictions on publication date.
Outcome measures
ET. can have clinical effects by improving dominant
symptoms, and we therefore chose to primarily focus on
the core symptoms of MSCs: 1) any measure of pain,
and 2) physical disability or physical function.
In addition, we collected data on the effect of ET on
disease pathogenesis, and whether particular components
of exercise programs are associated with the magnitude
of treatment effects.
We did not focus on the general health benefits or
complications of exercise because small to medium ran-
domized controlled trials (RCTs) with short-term to
intermediate follow-up may be inadequate to assess other
health benefits such as the cardiovascular risk profile and
the incidence of complications. Other potentially relevant
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outcomes, such as work participation and health-related
quality of life, compliance, or costs, were not evaluated.
Data collection and analysis
One reviewer (GS) extracted data on population, inter-
vention, comparison, and outcomes (inclusion criteria)
and the methodological quality of included trials. The
methodological quality was assessed using the AMSTAR
(A Measurement Tool to Assess Systematic Reviews)
checklist [13]. The 11 criteria shown in Table 1 were
rated as ‘met,’ ‘unclear/partly met,’ or ‘not met’. A sec-
ond reviewer (KBH) independently verified the accuracy
of the numeric results. Most reviews included several
comparisons, and we included analyses that compared
any exercise intervention with no or minimal exercise
intervention. Because pain and function most often are
continuous outcomes, data were summarized using the
standardized mean difference (SMD) or weighted mean
difference (WMD) with 95% confidence interval (95%
CI) as reported in the included reviews. For dichoto-
mous outcomes, odds ratio and 95% CI were presented.
Pooled effect estimates were presented according to the
model used in the reviews. For reviews that explored
whether particular components of exercise programs
were associated with the magnitude of treatment effects,
we extracted the coefficients from meta-regression or
sub-group analyses. Results from the review investigat-
ing the evidence for the effect of ET on disease patho-
genesis were reported as in the original review.
Results
We identified 18 potentially relevant Cochrane systematic
reviews. After reading the full text reviews, two were
excluded because they did not focus on land-based ET,
two because of irrelevant outcomes, four because of other
diagnoses, and finally four because they had not been
updated after January 2007 (for the excluded Cochrane
reviews and reason for exclusion, see Additional file 2).
The search for non-Cochrane reviews after 2007 resulted
in 963 references (474 for LBP, 186 for SP, 303 for NP).
Of these 963 references, 951 were excluded after screening
of the title and abstract and, 12 were retrieved as full text;
based on methodological quality and publication date 3 of
the latter were included.
Description of included reviews
We included six Cochrane systematic reviews on patients
with FM [14], OP [15], knee OA [16], hip OA [17], RA
[18] and AS [19]. In addition, three non-Cochrane reviews
comprising patients with SP [20], NP [21] and LBP [22]
were included. The nine included reviews comprised at
total of 224 trials with 24,059 patients. Characteristics of
the included reviews are shown in Table 2.
Four reviews [14,15,18,19] were assessed to be of high
methodological quality (all 11 criteria met), whereas in
three reviews [16,17,22] eight to nine criteria were met.
Finally, in two reviews [20,21] only three to four criteria
were met. In addition, we included one review which
investigated the evidence for the effect of ET on disease
pathogenesis [23].
Effects of exercises
The effects on clinical outcomes are summarized in
Table 3 (pain) and Table 4 (physical functioning).
Fibromyalgia
FM is characterized by persistent widespread musculos-
keletal pain and tenderness. In clinical practice, chronic
generalized musculoskeletal pain in all four quadrants of
the body that cannot be traced to a specific structural or
inflammatory cause is often diagnosed as FM. FM is also
associated with other symptoms such as fatigue, stiffness,
mood disturbance, abdominal pain, and headache. The
1990 American College of Rheumatology (ACR) diagno-
sis of FM was based on a history of widespread pain for a
duration of longer than 3 months, and the presence of
excessive tenderness on applying pressure to 11 of 18
specific muscle-tendon sites, whereas the preliminary
Table 1 The AMSTAR check list for methodological assessment.
No Item
1 Was an ‘a priori’ design provided?
2 Was there duplicate study selection and data extraction?
3 Was a comprehensive literature search performed?
4 Was the status of publication (that is, ‘gray’ literature) used as an inclusion criterion?
5 Was a list of studies (included and excluded) provided?
6 Were the characteristics of the included studies provided?
7 Was the scientific quality of the included studies assessed and documented?
8 Was the scientific quality of the included studies used appropriately in formulating conclusions?
9 Were the methods used to combine the findings of studies appropriate?
10 Was the likelihood of publication bias assessed?
11 Were potential conflicts of interest included?
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Patient inclusion criteria Included
trials/
patients









August 2008 Non-specific low back pain (with or without leg
pain) 12 weeks or longer
41/4485 Mean PEDro scoresb: 6.33 for exercise versus no treatment), and
5.82 for exercise versus minimal intervention
Met: 2, 3, 4, 5, 6, 7, 8 and 9;
not met: 10, 11; unclear: 1
Neck pain
[21]
February 2008 Non-specific neck pain in adults 33/6218 Mean PEDro scores: 5.67 Met: 2, 6, 7, 11; not met: 3,
4, 5, 8, 9, 10; unclear: 1
Shoulder pain
[20]
March 2011 Primary symptom of shoulder pain in adults 17/1436 Mean PEDro scores: 5.87 Met: 5, 7, 11; not met: 3, 4,
8, 10; unclear: 1, 2, 6, 9
Osteoporosis
[15]
December 2010 Healthy postmenopausal aged women between
45 and 70 years
43/4320 Most trials were scored as ‘unclear’ for randomization, allocation




December 2007 Knee OA based on accepted criteria or self-
reported knee OA on the basis of chronic joint
pain
32/3616 Of 43 trials, 9 (28 % ) studies had low risk of bias Met: 1, 2, 4, 5, 6, 7, 8, 9, 11;
not met: 3, 10
Osteoarthritis
(hip) [17]
August 2008 Hip OA based on accepted criteria or self-
reportedhip OA
5/267 Of 5 trials, 3 had low risk of bias and 2 trials had moderate risk of
bias
Met: 1, 2, 4, 5, 6, 7, 8, 9, 11;
not met: 3, 10
Rheumatoid
Arthritis [18]
December 2008 Adults with classic or definite RA based on
established criteria




January 2007 AS based on the modified New York criteria 11/763 Of 11 trials, 3 had low risk of bias; 3 had moderate risk of bias,
and 5 had high risk of bias
Met: all
avan Tulder quality scores for internal validity (0 to 11 scale).



























Aerobic training Various (wait list, control, no
exercise, treatment as usual)
3/183 SMDa 0.65 (95% CI -0.09 to 1.39)
Strength training Control (not specified) 1/21 SMD 3.00 (95% CI 1.68 to 4.32)
Low back pain
[22]
Exercise (many different types) No treatment 5/NRb WMDc -9.27 on a 100-point scale
(95% CI-17.00 to -1.55)
Minimal care 11/NR WMD -4.83 on a 100-point scale
(95% CI -9.36 to -0.30)
Neck pain [21] General strength and conditioning
exercises
Minimal or no intervention 3/76 WMD -12.00 on a 100-point scale
(95% CI -22.00 to -2.00)
Shoulder pain
[20]
Graded exercise therapy, progressive
resistance, active range of motion
Active or no intervention 3/273 SMD -0.30 (95% CI -0.48 to -0.12)
Osteoporosis
[15]





Any land-based therapeutic exercise
regimens
Various (not specified) 32/3616 SMD -0.40 (95% CI -0.50 to -0.30)
Osteoarthritis
hip [17]
Any land-based therapeutic exercise
regimens
Various (not specified) 5/204 SMD -0.33 (95% CI -0.84 to 0.17)
Rheumatoid
arthritis [18]
Short-term aerobic capacity and muscle-
strength training
Various (not specified) 1/50 SMD -0.53 (95% CI -1.09 to 0.04)
Short-term aerobic capacity training only Various (not specified) 1/56 SMD -0.27 (95% CI -0.79 to 0.26)
Ankylosing
spondylitis [19]
Supervised home exercise program No intervention 1/155 SMD 0.49 (95% CI 0.17 to 0.81)
a Standardized mean difference.
bNot reported.
cWeighted mean difference.
Table 4 Effect of exercise therapy on physical functioning.
Diagnosis
[Reference]






Aerobic training Various (wait list, control, no
exercise, treatment as usual)
4/253 SMDa 0.66 (95% CI 0.41 to 0.92)
Strength training Control (not specified) 2/47 SMD 0.52 (95% CI -0.07 to 1.10)
Low back pain
[22]
Exercise (many different types) No treatment 9/NRb WMDc -3.31 on a 100-point
scale (95% CI -4.83 to -1.79)
Minimal care 14/NR WMD -6.41 on a 100-point scale
(95% CI -9.76 to -3.05)
Neck pain [21] General strength and conditioning
exercises
Minimal or no intervention 2/141 WMD 1.00 on a 100-point scale
(95% CI -3.00 to 5.00)
Shoulder pain
[20]
Graded exercise therapy, progressive
resistance, active range of motion
Active or no intervention 4/358 SMD 0.15 (95% CI 0.01 to 0.29)
Osteoporosis
[15]





Any land-based therapeutic exercise
regimen




Any land-based therapeutic exercise
regimen
Various (not specified) 5/187 SMD -0.10 (95% CI -0.51 to 0.32)
Rheumatoid
arthritis [18]
Short-term aerobic capacity and muscle-
strength training
Various (not specified) 2/74 SMD -0.40 (95% CI -0.86 to 0.06)
Short-term aerobic capacity training only Various (not specified) 2/66 SMD -0.03 (95% CI -0.46 to 0.51)
Ankylosing
spondylitis [19]
Supervised home exercise program No intervention 1/155 SMD 0.12 (95% CI -0.20 to 0.43)
a Standardized mean difference.
b Not reported.
c Weighted mean difference.
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2010 ACR criteria are based on a combination of wide-
spread pain and multi-symptom severity, and do not
require a physical or tender-point examination [24].
The Cochrane review of Busch et al. [14] compared
first aerobic-only exercise interventions (only protocols
of intensity recommended by the American College of
Sports Medicine) with untreated control groups. Statisti-
cal pooling based on three trials with 183 patients indi-
cated a positive non-significant effect on pain in favor of
exercise (SMD = 0.65; 95% CI -0.09 to 1.39) and a signifi-
cant effect in physical function (3 trials with 253 patients)
(SMD 0.66; 95% CI 0.41 to 0.92). Later, meta-analyses
from two low-quality trials compared strength-only exer-
cise interventions with untreated control groups, and
found a large and significant effect on pain (based on one
trial with twenty-one patients) (SMD 3.00; 95% CI 1.68
to 4.32), and a non-significant effect in physical function:
(SMD 0.52; 95% CI -0.07 to 1.10). Based on the number
and quality of included trials, Bush et al. concluded that
there was evidence of a moderate quality showing that
short-term aerobic training at the intensity recom-
mended for increases in cardiorespiratory fitness have
beneficial effects on physical function and possibly pain.
We were not able to identify any analyses exploring the
effects of particular components of exercise. Pedersen
and Saltin [23] found limited evidence for the effect of
exercise on pathogenesis, that is, at least one relevant
study of moderate quality is available.
Low back pain
LBP is generally defined as pain located between the low-
est ribs and the inferior gluteal folds, with or without
pain radiation to the legs [25]. Clinical guidelines classify
LBP into 1) ‘non-specific’ LBP, 2) LBP affecting the nerve
root, and 3) possible serious spinal pathology (’red flags’)
[26]. After 1 month with LBP symptoms, a specific cause
can be identified for approximately 15% of patients [25].
Clinically, patients with LBP form a heterogeneous group
presenting with pain of varying duration, and disability in
terms of impairment of body function and structures,
limitations on activity, and restrictions on participation
in work and leisure.
The review by Ferreira et al. [22] sought to establish
the effect of exercise on pain and disability in patients
with chronic non-specific LBP, with the main aim of
explaining heterogeneity between trials. For exercise ver-
sus minimal care (11 trials), they found a significant
weighted mean difference (WMD) of -4.83 (on a 0 to 100
scale) favoring exercise for pain, (95% CI -9.36 to -0.30).
For exercise versus no treatment (five trials) the WMD
was also significantly in favor of exercise (-9.27, 95% CI
-17.00 to -1.55). Further, they found positive and signifi-
cant effects for disability. For exercise versus minimal
care (14 trials), the WMD was -6.41 (95% CI -9.76 to
-3.05), and for exercise versus no treatment (9 trials), the
WMD was -3.31 (95% CI -4.83 to -1.79).
Ferreira et al. [22] also explored between-trial variability
by meta-regression analyses, and found that only dosage
was significantly associated with effect size in pain.
‘Dosage’ means number of exercise hours and sessions,
and the results suggest that for each additional exercise
session, the effect size would increase by 0.13 (95% CI
0.02 to 0.24) on a 100-point scale. There was no evidence
for the effect of exercises on pathogenesis.
Neck pain
Although there is no general agreement on the classifica-
tion of NP, the Task Force on Neck Pain and its Asso-
ciated Disorders [27] suggested a classification of NP
severity from grade 1 (no signs or symptoms suggestive
of major structural pathology and no or minor interfer-
ence with activities of daily living; will probably respond
to minimal intervention such as reassurance and pain
control; does not require intensive investigations or
ongoing treatment) to grade IV (signs or symptoms of
major structural pathology, such as fracture, myelopathy,
neoplasm, or systemic disease; requires prompt investiga-
tion and treatment). Most people with NP do not recover
completely, and between 50% and 85% of those who
experience NP at some initial point will report it again 1
to 5 years later [28].
Leaver et al. [21] reported pooled outcomes from three
trials showing significant reductions in pain (on a scale of
0 to 100) at the conclusion of a course of specific exer-
cises (WMD -12.00, 95% CI -22.00 to -2.00). Pooled
results from two trials that reported disability outcomes
after general strength and conditioning exercise showed
no significant difference compared with minimal inter-
vention at the conclusion of treatment (WMD 1.00, 95%
CI -3.00 to 5.00). We were not able to identify any
reviews exploring between-trial heterogeneity or the
effect of exercises on pathogenesis.
Shoulder pain
SP and shoulder disorders cover a broad spectrum of
pain, symptoms, and diagnoses, including tendonitis,
rotator-cuff disease, sub-acromial pain, impingement
syndrome, and repetitive strain injury. As with NP, there
is no general agreement on the classification of painful
shoulder conditions [29]. Clinically, patients often pre-
sent with SP together with stiffness, reduced range of
motion, and/or with pain, or other symptoms radiating
to the more proximal part of the arm.
Marinko et al. [20] included three studies on SP with
pain as an outcome, and compared the effects of exer-
cise versus other treatments on pain levels. Data were
pooled by use of a random-effects model, which showed
an overall SMD in favor of the exercise intervention
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(SMD -0.30; 95% CI -0.48 to -0.12). Four studies
included function as an outcome, and compared the
effect of exercise versus an alternative intervention or
no intervention. Data were pooled by use of a random-
effects model, with an overall SMD of 0.15 (95% CI 0.01
to 0.29), indicating a minimal positive effect over no
care or alternative interventions. We were not able to
identify any reviews exploring between-trial heterogene-
ity or the effect of exercise on pathogenesis.
Osteoporosis
OP is characterized by a decrease in bone mineral density
(BMD), resulting in an increased risk of fracture. The
diagnostic criterion for OP is defined as BMD of more
than 2.5 standard deviations below the mean bone den-
sity of young adult women, whereas the term ‘established
osteoporosis’ includes the presence of a fragility fracture
[30]. Clinically, OP is recognized by characteristic frac-
tures after minimal traumas, most often in the hip, ver-
tebrae, or distal forearm. Clinical consequences of OP
fractures include pain and physical disability, with loss of
independence and need for long-term care as a conse-
quence. Increased mortality is also seen as a direct result
of fracture.
In the Cochrane review ‘Exercise for preventing and
treating osteoporosis in postmenopausal women’, Howe
et al. [15] identified 43 RCTs with more than 4000 partici-
pants. None of the studies included pain or physical func-
tion as an outcome. Concerning disease pathogenesis in
terms of BMD, meta-analyses from 24 RCTs with 1,441
participants showed significant differences in favor of exer-
cise for percentage change in BMD at the spine (MD 0.85;
95% CI 0.62 to 1.07), and trochanter (10 RCTs with 815
participants; MD 1.03; 95% CI 0.56 to 1.49) for the com-
parison of any exercise to any non-exercise control. Thus,
there is strong evidence for the effect of exercise on the
pathogenesis of OP, which was also confirmed by Peder-
sen and Saltin [23]. When exploring the most effective
intervention for BMD at the spine, Howe et al. [15] found
a combination of exercise programs (MD 3.22; 95% CI
1.80 to 4.64) to be most effective, whereas non-weight-
bearing high force exercise such as progressive resistance
strength training for the legs was most effective for the
neck of the femur (MD 1.03; 95% CI 0.24 to 1.82). Preven-
tion of fractures is a main aim in management strategies
for OP, and Howe et al. [15] reported that the risk of frac-
ture in exercise groups was not significantly different from
that in controls (OR 0.61; 95% CI 0.23 to 1.64 for four
RCTs and 539 participants).
Osteoarthritis
OA is most frequently seen in the hands, hips, and knees,
and is characterized by joint pain, stiffness, and func-
tional limitations. From being thought of as a simple
degenerative disease, there is now increasing evidence for
the involvement of inflammation in OA [31]. The term
‘symptomatic OA’ is used when both joint-related symp-
toms and radiographic signs are present [32].
Although evidence-based recommendations for the
treatment of OA consider exercise as a cornerstone of
modern OA management, the research evidence from
clinical trials in hand OA is very limited and conflicting
[33]. For hip OA, Fransen et al. [17] included 5 RCTs
with 204 patients, and reported a small, non-significant
effect of exercise on pain in patients with hip OA (SMD
-0.33, 95% CI -0.84 to 0.17). For physical function, the
effect was also small and non-significant (SMD -0.10,
95% CI -0.51 to 0.32). The amount of research evidence
for knee OA is substantially larger. Fransen et al. [16]
pooled the results from 32 RCTs with more than 3,600
patients, and reported a beneficial effect of exercise with
a SMD of -0.40 (95% CI -0.30 to -0.50) for pain; and
SMD of -0.37 (95% CI -0.25 to -0.49) for physical func-
tion. Interestingly, sub-group analyses showed that stu-
dies evaluating programs providing at least 12 direct
supervision occasions produced significantly greater
effects than programs providing less than 12 supervised
sessions for both pain ((SMD -0.46; 95% CI -0.60 to
-0.32) versus SMD -0.28 (95% CI -0.40 to -0.16)) and
function ((SMD -0.45; 95% CI -0.62 to -0.29) versus
SMD -0.23 (95% CI -0.37 to -0.09)].
According to Pedersen and Saltin [23], there is no evi-
dence for the effect of exercise on the pathogenesis of
OA.
Rheumatoid arthritis
RA is the most common inflammatory rheumatic joint
disease. The systemic inflammation leads to synovitis and
bone erosion, primarily affecting the small joints of
hands and feet, but the larger joints can also be involved.
Further, RA is associated with extra-articular features
and substantial co-morbidity, and a considerably
increased risk of cardiovascular disease (CVD) has been
reported [34]. The most typical clinical features of RA
are joint pain, stiffness, and reduced physical functioning.
In their Cochrane review of dynamic exercises for RA,
Hurkmans et al. [18] identified eight RCTs in total. For
short-term aerobic capacity and muscle-strength training,
statistical pooling of two trials (74 patients) showed a non-
significant trend for a positive effect of exercise on func-
tional ability (SMD -0.40, 95% CI -0.86 to 0.06), and data
from one trial (50 patients) indicated a similar effect on
pain (SMD -0.53, 95% CI -1.09 to 0.04). For short-term
aerobic exercise only, the meta-analysis showed SMD of
-0.27 (95% CI -0.79 to 0.26) for the effects of exercise on
pain (1 trial with 56 patients), and SMD of -0.03 (95% CI
-0.46 to 0.51) for functional ability (2 trials with 66
patients). We were not able to identify any analyses
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exploring the effects of particular components of exercise
on the effect on clinical outcomes, and there is no evi-
dence for the effect of exercise on the pathogenesis of RA
[23].
Ankylosing spondylitis
AS is a chronic inflammatory rheumatic disease predomi-
nantly affecting the axial skeleton and the sacroiliac
joints. The main clinical characteristics are pain, stiffness,
and loss of spinal mobility, caused by inflammation and
damage of spinal structures [35]. Other common features
of AS are peripheral arthritis, enthesitis, and anterior
uveitis, and recent research has also shown that AS is
associated with an increased risk of CVD[36]. Radio-
graphic sacroiliitis has traditionally been the diagnostic
hallmark of AS, but the absence of definite radiographic
sacroiliitis in the early disease stage has resulted in delays
in diagnosis. Efforts have therefore been made to facili-
tate an early, pre-radiological diagnosis of axial spondy-
loarthritis [37].
When comparing home exercises with no intervention
(1 trial with 155 patients), Dagfinrud et al. [19] found a
significant positive effect of exercise on pain for patients
with AS (SMD 0.49; 95% CI 0.17 to 0.81), and a non-sig-
nificant effect on function (SMD 0.12; 95% CI -0.20 to
0.43). There is, to our knowledge, no evidence for the
effect of exercise on the pathogenesis of AS, or whether
particular components of exercise can improve clinical
outcome.
Discussion
In this overview of systematic reviews on ET for muscle
and bone health, we included 9 systematic reviews with a
total of 224 trials and 24,059 patients. Overall, we found
a substantial amount of empirical evidence supporting
ET as a mainstay in the management of MSCs. However,
there are differences in the number of included trials
between the diagnostic groups included in the present
overview. For common conditions such as chronic non-
specific LBP and knee OA, there is a substantial number
of trials with relatively consistent results showing that
exercise has small to moderate beneficial effects on pain
and function. For others, such as the inflammatory joint
diseases (RA and AS), there are only one or two trials
comparing exercises with non-exercise or minimal exer-
cise interventions. When comparing the effect sizes on
pain and physical functioning, there seems to be a trend
towards larger effects of exercise on pain. The effect sizes
were generally larger for pain than for physical function,
with significant positive effects for pain in six conditions
and for physical function in five conditions. This may
indicate that there is no linear relationship between
symptoms and functioning, and it may suggest that a
relatively large reduction in symptoms is needed to
improve physical function. There are also several other
important components influencing function, such as
environmental and personal factors.
We also intended to explore the evidence for the effect
of ET on disease pathogenesis. However, we were not able
to identify evidence for the influence of pathogenesis in
MSCs, except for OP. Although the disease mechanisms
for the common MSCs are largely unknown, there seems
to be a gap in the understanding of why ET improves clin-
ical outcome. From a clinical point of view, the most inter-
esting question is ‘which exercises for which patients?’. We
therefore also explored whether particular components of
exercise programs are associated with the size of the treat-
ment effects. Because we did not include single trials com-
paring different exercise interventions, we could only
identify indirect comparisons from the reviews. For LBP
and knee OA, for which the substantial number of trials
allowed explorative sub-group or meta-regression analyses,
the results suggest that ‘more is better’; that is, that the
treatment effect increases with the number of exercise ses-
sions. However, it is unclear whether the estimated
increase is of clinical relevance.
One previous overview has addressed the effect of ET
for MSCs [12]. Dziedzic et al. also concluded that ET is a
beneficial component of the management of MSCs
because it reduces pain and disability, and that there is
limited evidence for the benefit of one particular approach
to exercise over another. However, they also emphasized
one important clinical caveat, namely that there is evi-
dence that exercise should not be recommended for acute
LBP [12], which was also supported by an updated sys-
tematic review [38].
There are several methodological challenges in summar-
izing evidence from systematic reviews only. There is a
substantial number of new trials published in this field
every year, and systematic reviews published some years
ago may therefore not be based on the most up-to-date
evidence. We therefore intended to include Cochrane
reviews, because these should be regularly updated. How-
ever, this overview clearly shows that this is not the case.
We excluded three out of nine eligible Cochrane reviews
because they had not been updated after 2007. The deci-
sion to exclude Cochrane reviews that had not been
updated during the previous five years was arbitrarily cho-
sen and is open to debate. However, considering the sub-
stantial number of new trials that have been published on
this topic in the past few years, we would suggest that
including reviews that are more than 5 years old would
not reflect the most up-to-date evidence. Although we
performed extensive literature searches, the selection of
the three non-Cochrane reviews can also be questioned.
However, other systematic reviews on the effects of exer-
cises for LBP, NP and SP also found more or less similar
results. For LBP, Macedo et al. [39] systematically
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reviewed 14 RCTs on the effects of motor control exer-
cises for persistent LBP. Their pooled estimates for the
comparison between motor control exercise and minimal
intervention in reducing pain and disability in both the
short and long term were higher than those in the review
of Ferreira et al. [21]. van Middelkoop et al. [40] provided
an overview on the effects of ET in patients with chronic
LBP; they included 37 RCTs that compared exercise with
usual care and found that ET improved post-treatment
pain intensity and disability. They also found no evidence
that one particular type of ET was clearly more effective
than others. In a review of nine trials on the effects of var-
ious types of exercise for prevention and cure of non-spe-
cific NP in office workers, Sihawong et al. [41] found
strong evidence for the effects of muscle strengthening
and endurance exercises in treating NP. Moderate evi-
dence supported the use of muscle endurance exercise in
reducing disability attributed to NP. Teasell et al. [42]
reviewed the strength of evidence supporting various
therapies for whiplash-associated disorder (WAD). They
included 40 trials, and found that exercise and mobiliza-
tion programs for acute and chronic WAD had the stron-
gest supporting evidence, although many questions remain
about the relative effects of various protocols. For SP, a
recent systematic review of four RCTs examining the
effects of exercise for rotator-cuff tendinopathy concluded
that the available literature was supportive that exercise
reduced pain and functional disability [43]. In a systematic
review from 2011, Brudvig et al. [44] summarized the pub-
lished research evidence on the effects of therapeutic exer-
cise and joint mobilization compared with therapeutic
exercise alone in patients with shoulder dysfunction. They
found no evidence for the beneficial effects of the combi-
nation of therapeutic exercise and joint mobilization ver-
sus therapeutic exercise alone for reducing pain and
increasing function.
An interesting finding of the present study is that
Cochrane reviews seem to be of higher methodological
quality than non-Cochrane reviews, which is also consis-
tent with reviews specifically addressing this issue
[45,46]. Because reviews provide limited information
about included trials, the conclusions from tertiary
research (overview of systematic reviews) may become
too general to be considered as clinically relevant. How-
ever, we suggest that findings from overviews can be
valuable as a ‘compass’ for the clinician, and that the
decision on the type, dose, and timing of intervention
should be shared between the clinician and patient at
each clinical encounter. Another limitation related to
clinical relevance is the magnitude of the estimated
effect sizes. Using a traditional and very rough defini-
tion, SMDs between 0.30 and 0.65 can be considered as
small to moderate. However, whether the effects are
clinically worthwhile is a complex question that should
also include the patient’s perceptions of risks and costs
with the actual treatment. The definition of relatively
broad diagnostic groups used in the present overview
might also be considered as a limitation from a clini-
cian’s point of view. For the regional pain syndromes
(LBP, SP, and NP) it is obvious that one size does not
fit all; that is, that the effect of ET might not be equal
across diagnostic sub-groups. For example, for back
pain a recent randomized trial compared stratification of
the management based on the patient’s prognosis with
non-stratified current best practice, and found that stra-
tified care produced disease-specific and general health
benefits [47].
Although few reviews addressed potential adverse
effects (AEs), exercise for people with MSCs is generally
safe and well tolerated, but patients may report minor
AEs of exercise such as pain and discomfort [48]. For
OP, Howe et al. [15] found that fractures and falls were
reported as AEs in some studies, but there was no sig-
nificant effect on the numbers of fractures. By contrast,
results from a systematic review showed that exercise
can reduce falls, fall-related fractures, and several risk
factors for falls in individuals with low BMD [49]. In
general, there are few contraindications to prescription
of exercise, but co-morbidities should be considered.
When prescribing ET as part of the disease manage-
ment, the exercise program must be individually
adopted and targeted depending on the disease severity
of the individual patient, and on their physical fitness
and any co-morbid conditions. A number of co-morbid-
ities may have an influence on the burden and prognosis
of MSCs; in particular, inflammatory rheumatic diseases
are associated with a considerably increased risk for
CVD [36].
Conclusions
In conclusion, the present overview shows that ET can
decrease pain and improve physical functioning, but
there were substantial differences in the amount of
research evidence across the included diagnostic groups.
For example, the relevant comparison for knee OA
included 32 trials with more than 3,600 patients,
whereas the results for RA and AS are based on one or
two trials with between 50 and 150 patients. Conse-
quently, the pooled estimates for knee OA, LBP, FM,
and SP showed consistently significant effects in favor of
exercise for both outcomes, whereas for NP, hip OA,
RA, and AS, the effect estimates were generally smaller
and not always significant. However, for the manage-
ment of all MSCs included in the present overview, ET
is unanimously recommended.
There are, however, important limitations when it
comes to implications for clinical practice and research.
Firstly, for prescription of exercise programs with
Hagen et al. BMC Medicine 2012, 10:167
http://www.biomedcentral.com/1741-7015/10/167
Page 9 of 11
optimal health benefits for the individual patient, more
knowledge is needed on which particular elements and
modes of ET, as well as the doses and frequency of
delivery, can improve the outcomes of interest. Sec-
ondly, knowledge of the potential influence of ET on
disease parthenogenesis and the long-term effects on
disease progression is currently very limited. Thirdly, it
is still an open question whether the magnitude of the
positive effects is clinically worthwhile and whether ET
is a cost-effective intervention.
Note
* = included reviews
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